Brought to you by 
Syn X raises $12.8mm in public offering
04 May 2001
Executive Summary
Syn X (rapid antibody-based diagnostics and drug discovery for diseases associated with syndrome X) grossed $12.8mm ($Cdn19.7mm) through an offering of just over 2.8mm special warrants, including the overallotment, priced at $4.56 ($Cdn7) each. The warrants are convertible into one common share.
Deal Industry
- In Vitro Diagnostics
-
In Vitro Diagnostics
- Chemistry, Immunoassay
-
Biotechnology
-
Drug Discovery Tools
- Genomics-Proteomics
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Financing
- FOPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Syn X raises $12.8mm in public offering
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice